HMGB1 and lung carcinoma: Han et al. found that dihydroartemisinin promoted immunogenic death in lung cancer mice, increased the expression of related proteins (MHC-I, CRT, and HSP90), and upregulated HMGB1 expression (Han et al., 2023).